Literature DB >> 24554827

Atypical mycobacterial infection in hairy cell leukemia treated with cladribine.

Chandramohan Ramasamy1, Biswajit Dubashi2, J Sree Rekha3, Debdatta Basu3, Ankit Jain2, Tarun Kumar Dutta1.   

Abstract

We report a case of hairy cell leukemia who improved after cladribine but succumbed to disseminated atypical mycobacterial infection 2 months after completing cladribine.

Entities:  

Year:  2012        PMID： 24554827      PMCID： PMC3921339          DOI： 10.1007/s12288-012-0196-1

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN： 0971-4502            Impact factor:   0.900


  5 in total

Review 1.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors:  David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

2.  Extended follow-up of patients with hairy cell leukemia after treatment with cladribine.

Authors:  Grant R Goodman; Carol Burian; James A Koziol; Alan Saven
Journal:  J Clin Oncol       Date:  2003-03-01       Impact factor: 44.544

3.  Infectious complications in 127 patients with hairy cell leukemia.

Authors:  H M Golomb; L J Hadad
Journal:  Am J Hematol       Date:  1984-05       Impact factor: 10.047

Review 4.  Hairy cell leukemia: current concepts.

Authors:  Timothy Cannon; Dalia Mobarek; Julia Wegge; Imad A Tabbara
Journal:  Cancer Invest       Date:  2008-10       Impact factor: 2.176

5.  Disseminated atypical mycobacterial infection in patients with hairy cell leukemia.

Authors:  C Bennett; J Vardiman; H Golomb
Journal:  Am J Med       Date:  1986-05       Impact factor: 4.965
  5 in total
  1 in total

1.  Analysis of a cohort of 279 patients with hairy-cell leukemia (HCL): 10 years of follow-up.

Authors:  Jerome Paillassa; Edouard Cornet; Stephanie Noel; Cecile Tomowiak; Stephane Lepretre; Sandrine Vaudaux; Jehan Dupuis; Alain Devidas; Bertrand Joly; Charlotte Petitdidier-Lionnet; Stephanie Haiat; Clara Mariette; Catherine Thieblemont; Didier Decaudin; Patricia Validire-Charpy; Bernard Drenou; Jean-Claude Eisenmann; Mario Ojeda Uribe; Agnès Olivrie; Mohamed Touati; Olivier Lambotte; Olivier Hermine; Jean-Michel Karsenti; Pierre Feugier; Willy Vaillant; Jean Gutnecht; Eric Lippert; Fabienne Huysman; Kamel Ghomari; Marouane Boubaya; Vincent Levy; Jeremie Riou; Gandhi Damaj; Aline Tanguy-Schmidt; Mathilde Hunault-Berger; Xavier Troussard
Journal:  Blood Cancer J       Date:  2020-05-27       Impact factor: 11.037
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.